126 related articles for article (PubMed ID: 29031951)
1. Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations.
Chaurasia S; Patel RR; Vure P; Mishra B
J Pharm Sci; 2018 Feb; 107(2):706-716. PubMed ID: 29031951
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
3. Oral naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments.
Chaurasia S; Patel RR; Vure P; Mishra B
Nanomedicine (Lond); 2017 Jun; 12(11):1243-1260. PubMed ID: 28593828
[TBL] [Abstract][Full Text] [Related]
4. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
Patil SS; Roy K; Choudhary B; Mahadik KR
Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
[TBL] [Abstract][Full Text] [Related]
6. Naringenin-Zinc Oxide Nanocomposites Amalgamated Polymeric Gel Augmented Drug Delivery and Attenuated Experimental Cutaneous Candidiasis in Balb/c Mice: In Vitro and In Vivo Studies.
Katta CB; Bahuguna D; Veerabomma H; Gollapalli S; Shaikh AS; Bhale NA; Dikundwar AG; Kaki VR; Singh PK; Madan J
AAPS PharmSciTech; 2024 Jun; 25(5):130. PubMed ID: 38844611
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine Nanoparticle Laden Polymer Composite Oral Dissolving Films for Improving Therapeutic Potential of the Hydrophobic Antiepileptic Molecule.
Shankar Raman S; Narayanan VHB; Durai R
Assay Drug Dev Technol; 2021 Jan; 19(1):2-16. PubMed ID: 33216611
[No Abstract] [Full Text] [Related]
8. Chitosan Oligosaccharide Modified Bovine Serum Albumin Nanoparticles for Improving Oral Bioavailability of Naringenin.
Fang R; Liao Y; Qiu H; Liu Y; Lin S; Chen H
Curr Drug Deliv; 2024; 21(8):1142-1150. PubMed ID: 37464826
[TBL] [Abstract][Full Text] [Related]
9. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Naringenin Nanoparticles to Improve the Antitussive Effects on Post-Infectious Cough.
Dong Z; Wang X; Wang M; Wang R; Meng Z; Wang X; Yu B; Han M; Guo Y
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744861
[TBL] [Abstract][Full Text] [Related]
15. Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation.
Yin J; Wang P; Yin Y; Hou Y; Song X
Drug Deliv; 2017 Nov; 24(1):1891-1897. PubMed ID: 29191042
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo.
Kiran Rompicharla SV; Trivedi P; Kumari P; Ghanta P; Ghosh B; Biswas S
Nanomedicine (Lond); 2017 Jan; 12(1):43-58. PubMed ID: 27879153
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects.
Dong Z; Wang R; Wang M; Meng Z; Wang X; Han M; Guo Y; Wang X
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164006
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Solubility and Bioavailability of Naringenin via Liposomal Nanoformulation: Preparation and In Vitro and In Vivo Evaluations.
Wang Y; Wang S; Firempong CK; Zhang H; Wang M; Zhang Y; Zhu Y; Yu J; Xu X
AAPS PharmSciTech; 2017 Apr; 18(3):586-594. PubMed ID: 27151135
[TBL] [Abstract][Full Text] [Related]
19. Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo.
Hari BNV; Narayanan N; Dhevendaran K; Ramyadevi D
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():522-532. PubMed ID: 27287151
[TBL] [Abstract][Full Text] [Related]
20. Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma.
Pareek A; Kothari R; Pareek A; Ratan Y; Kashania P; Jain V; Jeandet P; Kumar P; Khan AA; Alanazi AM; Gupta MM
Eur J Pharm Sci; 2024 Feb; 193():106642. PubMed ID: 37977235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
